Munich, Germany

Joerg Thomas


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Joerg Thomas: A Groundbreaking Inventor in Biopharmaceuticals

Introduction: Joerg Thomas is an accomplished inventor based in Munich, Germany, known for his innovative contributions to the field of biopharmaceuticals. With a keen focus on developing therapeutic antibodies, he has made significant strides in addressing critical medical challenges.

Latest Patents: Joerg Thomas holds one patent titled "Bispecific, bivalent anti-VEGF/anti-ANG-2 antibodies." This groundbreaking invention pertains to bispecific, bivalent antibodies that target human vascular endothelial growth factor (VEGF/VEGF-A) as well as human angiopoietin-2 (ANG-2). The patent outlines methods for producing these antibodies, pharmaceutical compositions containing them, and their various applications in medical treatments.

Career Highlights: Joerg Thomas is a pivotal member of Hoffmann-La Roche Inc., a leading pharmaceutical company dedicated to research and development in healthcare. His work focuses on creating innovative therapeutic solutions that can improve patient outcomes.

Collaborations: Throughout his career, Joerg Thomas has collaborated with talented coworkers such as Monika Baehner and Sabine Imhof-Jung. These partnerships emphasize the importance of teamwork in driving innovation in the biotech sector.

Conclusion: Joerg Thomas exemplifies the spirit of innovation within the biopharmaceutical industry. His patent on bispecific antibodies represents a significant advancement in targeted therapies, showcasing his commitment to improving healthcare through scientific discovery and collaboration.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…